SG Americas Securities’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-44,429
| Closed | -$896K | – | 3521 |
|
2021
Q3 | $896K | Buy |
44,429
+24,910
| +128% | +$502K | ﹤0.01% | 1836 |
|
2021
Q2 | $728K | Sell |
19,519
-1,531
| -7% | -$57.1K | ﹤0.01% | 1585 |
|
2021
Q1 | $538K | Sell |
21,050
-10,944
| -34% | -$280K | ﹤0.01% | 1804 |
|
2020
Q4 | $705K | Sell |
31,994
-2,190
| -6% | -$48.3K | ﹤0.01% | 1525 |
|
2020
Q3 | $615K | Buy |
34,184
+9,250
| +37% | +$166K | ﹤0.01% | 1247 |
|
2020
Q2 | $633K | Buy |
24,934
+8,948
| +56% | +$227K | 0.01% | 1583 |
|
2020
Q1 | $294K | Buy |
15,986
+7,069
| +79% | +$130K | ﹤0.01% | 1878 |
|
2019
Q4 | $196K | Sell |
8,917
-2,479
| -22% | -$54.5K | ﹤0.01% | 2147 |
|
2019
Q3 | $164K | Sell |
11,396
-14,403
| -56% | -$207K | ﹤0.01% | 2110 |
|
2019
Q2 | $406K | Sell |
25,799
-13,026
| -34% | -$205K | ﹤0.01% | 1748 |
|
2019
Q1 | $569K | Buy |
+38,825
| New | +$569K | 0.01% | 1518 |
|